Literature DB >> 3106353

Quantitative studies of hydroperoxide reduction by prostaglandin H synthase. Reducing substrate specificity and the relationship of peroxidase to cyclooxygenase activities.

C M Markey, A Alward, P E Weller, L J Marnett.   

Abstract

The peroxidase activity of prostaglandin H (PGH) synthase catalyzes reduction of 5-phenyl-4-pentenyl hydroperoxide to 5-phenyl-4-pentenyl alcohol with a turnover number of approximately 8000 mol of 5-phenyl-4-pentenyl hydroperoxide/mol of enzyme/min. The kinetics and products of reaction establish PGH synthase as a classical heme peroxidase with catalytic efficiency similar to horseradish peroxidase. This suggests that the protein of PGH synthase evolved to facilitate peroxide heterolysis by the heme prosthetic group. Comparison of an extensive series of phenols, aromatic amines, beta-dicarbonyls, naturally occurring compounds, and nonsteroidal anti-inflammatory drugs indicates that considerable differences exist in their ability to act as reducing substrates. No correlation is observed between the ability of compounds to support peroxidatic hydroperoxide reduction and to inhibit cyclooxygenase. In addition, the resolved enantiomers of MK-410 and etodolac exhibit dramatic enantiospecific differences in their ability to inhibit cyclooxygenase but are equally potent as peroxidase-reducing substrates. This suggests that there are significant differences in the orientation of compounds at cyclooxygenase inhibitory sites and the peroxidase oxidation site(s). Comparison of 5-phenyl-4-pentenyl hydroperoxide reduction by PGH synthase and horseradish peroxidase reveals considerable differences in reducing substrate specificity. Both the cyclooxygenase and peroxidase activities of PGH synthase inactivate in the presence of low micromolar amounts of hydroperoxides and arachidonic acid. PGH synthase was most sensitive to arachidonic acid, which exhibited an I50 of 0.6 microM in the absence of all protective agents. Inactivation by hydroperoxides requires peroxidase turnover and can be prevented by reducing substrates. The I50 values for inactivation by 15-hydroperoxy-5,8,11,13-eicosatetraenoic acid are 4.0 and 92 microM, respectively, in the absence and presence of 500 microM phenol, a moderately good reducing substrate. The ability of compounds to protect against hydroperoxide-induced inactivation correlates directly with their ability to act as reducing substrates. Hydroquinone, an excellent reducing substrate, protected against hydroperoxide-induced inactivation when present in less than 3-fold molar excess over hydroperoxide. The presence of a highly efficient hydroperoxide-reducing activity appears absolutely essential for protection of the cyclooxygenase capacity of PGH synthase. The peroxidase activity is, therefore, a twin-edged sword, responsible for and protective against hydroperoxide-dependent inactivation of PGH synthase.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3106353

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

Review 1.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

2.  Autoxidative and cyclooxygenase-2 catalyzed transformation of the dietary chemopreventive agent curcumin.

Authors:  Markus Griesser; Valentina Pistis; Takashi Suzuki; Noemi Tejera; Derek A Pratt; Claus Schneider
Journal:  J Biol Chem       Date:  2010-11-11       Impact factor: 5.157

3.  Heneicosapentaenoate (21:5n-3): its incorporation into lipids and its effects on arachidonic acid and eicosanoid synthesis.

Authors:  L N Larsen; K Høvik; J Bremer; K H Holm; F Myhren; B Børretzen
Journal:  Lipids       Date:  1997-07       Impact factor: 1.880

Review 4.  Mechanism-based therapeutic approaches to rhabdomyolysis-induced renal failure.

Authors:  Olivier Boutaud; L Jackson Roberts
Journal:  Free Radic Biol Med       Date:  2010-10-27       Impact factor: 7.376

5.  PAMAM dendrimers as nano carriers to investigate inflammatory responses induced by pulmonary exposure of PCB metabolites in Sprague-Dawley rats.

Authors:  Orarat Wangpradit; Andrea Adamcakova-Dodd; Katharina Heitz; Larry Robertson; Peter S Thorne; Gregor Luthe
Journal:  Environ Sci Pollut Res Int       Date:  2015-09-24       Impact factor: 4.223

Review 6.  Enantioselective pharmacodynamics and pharmacokinetics of chiral non-steroidal anti-inflammatory drugs.

Authors:  A M Evans
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

7.  Oxyferryl heme and not tyrosyl radical is the likely culprit in prostaglandin H synthase-1 peroxidase inactivation.

Authors:  Gang Wu; Corina E Rogge; Jinn-Shyan Wang; Richard J Kulmacz; Graham Palmer; Ah-Lim Tsai
Journal:  Biochemistry       Date:  2007-01-16       Impact factor: 3.162

Review 8.  Reciprocal regulation of the nitric oxide and cyclooxygenase pathway in pathophysiology: relevance and clinical implications.

Authors:  Daniela Salvemini; Sangwon F Kim; Vincenzo Mollace
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2013-02-06       Impact factor: 3.619

9.  Effects of arachidonic acid concentration on prostaglandin biosynthesis and feasibility of semibatch processes.

Authors:  E Sada; S Katoh; A Kheirolomoom
Journal:  Appl Biochem Biotechnol       Date:  1989-12       Impact factor: 2.926

10.  Prostaglandin H synthase dependent metabolism of diethylstilbestrol by ram seminal vesicle cell cultures.

Authors:  J Foth; G H Degen
Journal:  Arch Toxicol       Date:  1991       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.